{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:29:37Z","timestamp":1790321377590,"version":"4.1.0"},"reference-count":58,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T00:00:00Z","timestamp":1450742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Rett syndrome is an extremely disabling X-linked nervous system disorder that mainly affects girls in early childhood and causes autism-like behavior, severe intellectual disability, seizures, sleep disturbances, autonomic instability, and other disorders due to mutations in the MeCP2 (methyl CpG-binding protein 2) transcription factor. The disorder targets synapses and synaptic plasticity and has been shown to disrupt the balance between glutamate excitatory synapses and GABAergic inhibitory synapses. In fact, it can be argued that Rett syndrome is primarily a disorder of synaptic plasticity and that agents that can correct this imbalance may have beneficial effects on brain development. This review briefly summarizes the link between disrupted synaptic plasticity mechanisms and Rett syndrome and early clinical trials that aim to target these abnormalities to improve the outcome for these severely disabled children.<\/ns4:p>","DOI":"10.12688\/f1000research.6987.1","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T05:55:01Z","timestamp":1450763701000},"page":"1490","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Recent advances in understanding synaptic abnormalities in Rett syndrome"],"prefix":"10.12688","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3701-6028","authenticated-orcid":false,"given":"Michael V.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Blue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakkubai","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2015,12,22]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"5509-14","DOI":"10.1073\/pnas.1505909112","article-title":"MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.","volume":"112","author":"L Chen","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"312-4","DOI":"10.1038\/nrneurol.2011.64","article-title":"Neurodevelopmental disorders: Clinical criteria for Rett syndrome.","volume":"7","author":"S Naidu","year":"2011","journal-title":"Nat Rev Neurol."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"185-96","DOI":"10.1007\/s11689-009-9027-6","article-title":"Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism.","volume":"1","author":"C Chapleau","year":"2009","journal-title":"J Neurodev Disord."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"1887-901","DOI":"10.1016\/j.celrep.2015.08.028","article-title":"miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.","volume":"12","author":"K Tsujimura","year":"2015","journal-title":"Cell Rep."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"193-202","DOI":"10.1007\/s00109-010-0699-x","article-title":"Cell cloning-based transcriptome analysis in cyclin-dependent kinase-like 5 mutation patients with severe epileptic encephalopathy.","volume":"89","author":"J Nectoux","year":"2011","journal-title":"J Mol Med (Berl)."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"241-9","DOI":"10.1007\/s10048-009-0220-2","article-title":"Revisiting the phenotype associated with FOXG1 mutations: two novel cases of congenital Rett variant.","volume":"11","author":"N Bahi-Buisson","year":"2010","journal-title":"Neurogenetics."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"77-8; author reply 78","DOI":"10.1212\/01.wnl.0000349658.05677.d7","article-title":"Re: CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy.","volume":"73","author":"Y Fichou","year":"2009","journal-title":"Neurology."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fped.2014.00061","article-title":"New experimental treatments for core social domain in autism spectrum disorders.","volume":"2","author":"R Canitano","year":"2014","journal-title":"Front Pediatr."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"3-10","DOI":"10.1002\/ana.410420104","article-title":"Rett syndrome: a disorder affecting early brain growth.","volume":"42","author":"S Naidu","year":"1997","journal-title":"Ann Neurol."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"154-8","DOI":"10.1002\/mrdd.20030","article-title":"Rett syndrome: of girls and mice--lessons for regression in autism.","volume":"10","author":"D Glaze","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"127-35","DOI":"10.1016\/S1090-3798(98)80028-7","article-title":"Rett syndrome: critical examination of clinical features, serial EEG and video-monitoring in understanding and management.","volume":"2","author":"R Cooper","year":"1998","journal-title":"Eur J Paediatr Neurol."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"339-45","DOI":"10.1093\/ejechocard\/jer256","article-title":"Subclinical myocardial dysfunction in Rett syndrome.","volume":"13","author":"C de Felice","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2202-11-19","article-title":"Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome\/X-linked mental retardation.","volume":"11","author":"G Jentarra","year":"2010","journal-title":"BMC Neurosci."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"10021-34","DOI":"10.1523\/JNEUROSCI.1316-12.2012","article-title":"MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain.","volume":"32","author":"M Nguyen","year":"2012","journal-title":"J Neurosci."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/srep00045","article-title":"The short-time structural plasticity of dendritic spines is altered in a model of Rett syndrome.","volume":"1","author":"S Landi","year":"2011","journal-title":"Sci Rep."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"219-33","DOI":"10.1016\/j.nbd.2009.05.001","article-title":"Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.","volume":"35","author":"C Chapleau","year":"2009","journal-title":"Neurobiol Dis."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"747-53","DOI":"10.1177\/08830738050200090901","article-title":"Neuropathology of Rett syndrome.","volume":"20","author":"D Armstrong","year":"2005","journal-title":"J Child Neurol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"S206-13","DOI":"10.1016\/S0387-7604(01)00351-5","article-title":"Neurobiology of Rett syndrome: a genetic disorder of synapse development.","volume":"23","author":"M Johnston","year":"2001","journal-title":"Brain Dev."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"206-18","DOI":"10.1002\/ana.10633","article-title":"Olfactory biopsies demonstrate a defect in neuronal development in Rett\u2019s syndrome.","volume":"54","author":"G Ronnett","year":"2003","journal-title":"Ann Neurol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"212-3","DOI":"10.1055\/s-2008-1071344","article-title":"Elevated CSF glutamate in Rett syndrome.","volume":"23","author":"A Hamberger","year":"1992","journal-title":"Neuropediatrics."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"213-6","DOI":"10.1016\/S0887-8994(96)00218-4","article-title":"High levels of cerebrospinal fluid glutamate in Rett syndrome.","volume":"15","author":"R Lappalainen","year":"1996","journal-title":"Pediatr Neurol."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"345-52","DOI":"10.1006\/exnr.1999.7030","article-title":"Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome.","volume":"156","author":"M Blue","year":"1999","journal-title":"Exp Neurol."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"541-5","DOI":"10.1002\/1531-8249(199904)45:4<541::AID-ANA21>3.0.CO;2-2","article-title":"Development of amino acid receptors in frontal cortex from girls with Rett syndrome.","volume":"45","author":"M Blue","year":"1999","journal-title":"Ann Neurol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"90-7","DOI":"10.1002\/ana.21562","article-title":"Brain metabolism in Rett syndrome: age, clinical, and genotype correlations.","volume":"65","author":"A Horsk\u00e1","year":"2009","journal-title":"Ann Neurol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"1624-34","DOI":"10.1002\/ar.21380","article-title":"Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice.","volume":"294","author":"M Blue","year":"2011","journal-title":"Anat Rec (Hoboken)."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"13529-36","DOI":"10.1523\/JNEUROSCI.3077-12.2012","article-title":"A critical and cell-autonomous role for MeCP2 in synaptic scaling up.","volume":"32","author":"M Blackman","year":"2012","journal-title":"J Neurosci."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"217-27","DOI":"10.1016\/j.nbd.2005.07.005","article-title":"Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.","volume":"21","author":"Y Asaka","year":"2006","journal-title":"Neurobiol Dis."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"12560-5","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome.","volume":"102","author":"V Dani","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"294-309","DOI":"10.1002\/hipo.20389","article-title":"The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability.","volume":"18","author":"L Zhang","year":"2008","journal-title":"Hippocampus."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"624-32","DOI":"10.1016\/j.neuroscience.2010.03.065","article-title":"Diminished prevalence but preserved synaptic distribution of N-methyl-D-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain.","volume":"168","author":"E Maliszewska-Cyna","year":"2010","journal-title":"Neuroscience."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"1155-63","DOI":"10.1098\/rstb.1999.0471","article-title":"Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.","volume":"354","author":"P Magistretti","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"e560","DOI":"10.1038\/cddis.2013.82","article-title":"NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors.","volume":"4","author":"X Zhou","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"5346-56","DOI":"10.1523\/JNEUROSCI.5966-09.2010","article-title":"Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate.","volume":"30","author":"I Maezawa","year":"2010","journal-title":"J Neurosci."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"322-6","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.","volume":"27","author":"J Guy","year":"2001","journal-title":"Nat Genet."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"2516-29","DOI":"10.1523\/JNEUROSCI.2778-14.2015","article-title":"Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity.","volume":"35","author":"L Jin","year":"2015","journal-title":"J Neurosci."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"e35354","DOI":"10.1371\/journal.pone.0035354","article-title":"Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.","volume":"7","author":"Y Okabe","year":"2012","journal-title":"PLoS One."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"497-500","DOI":"10.1038\/nature10214","article-title":"A role for glia in the progression of Rett's syndrome.","volume":"475","author":"D Lioy","year":"2011","journal-title":"Nature."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"563-74","DOI":"10.1016\/j.neuroscience.2007.09.076","article-title":"Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia.","volume":"150","author":"J Russell","year":"2007","journal-title":"Neuroscience."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"179-82","DOI":"10.1016\/0304-3940(96)12918-9","article-title":"State-dependent changes of extracellular glutamate in the medial preoptic area in freely behaving rats.","volume":"214","author":"S Azuma","year":"1996","journal-title":"Neurosci Lett."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnsys.2014.00118","article-title":"Twenty-four hour quantitative-EEG and in-vivo glutamate biosensor detects activity and circadian rhythm dependent biomarkers of pathogenesis in Mecp2 null mice.","volume":"8","author":"M Johnston","year":"2014","journal-title":"Front Syst Neurosci."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"263-9","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.","volume":"468","author":"H Chao","year":"2010","journal-title":"Nature."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"21-8","DOI":"10.4137\/JCNSD.S14012","article-title":"Temporal- and Location-Specific Alterations of the GABA Recycling System in Mecp2 KO Mouse Brains.","volume":"6","author":"S Kang","year":"2014","journal-title":"J Cent Nerv Syst Dis."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"e92169","DOI":"10.1371\/journal.pone.0092169","article-title":"GABA and glutamate pathways are spatially and developmentally affected in the brain of Mecp2-deficient mice.","volume":"9","author":"R El-Khoury","year":"2014","journal-title":"PLoS One."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"684-98","DOI":"10.1016\/j.neuron.2015.07.033","article-title":"Excitatory\/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.","volume":"87","author":"S Nelson","year":"2015","journal-title":"Neuron."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"E4782-91","DOI":"10.1073\/pnas.1506499112","article-title":"MeCP2 regulates the timing of critical period plasticity that shapes functional connectivity in primary visual cortex.","volume":"112","author":"K Krishnan","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"1681-3","DOI":"10.1126\/science.1091032","article-title":"Specific GABAA circuits for visual cortical plasticity.","volume":"303","author":"M Fagiolini","year":"2004","journal-title":"Science."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"1078-90","DOI":"10.1016\/j.neuron.2012.12.004","article-title":"NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2.","volume":"76","author":"S Durand","year":"2012","journal-title":"Neuron."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1038\/ncomms6036","article-title":"Conditional deletion of Mecp2 in parvalbumin-expressing GABAergic cells results in the absence of critical period plasticity.","volume":"5","author":"L He","year":"2014","journal-title":"Nat Commun."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"13860-72","DOI":"10.1523\/JNEUROSCI.2159-12.2012","article-title":"Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment.","volume":"32","author":"M Kron","year":"2012","journal-title":"J Neurosci."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"959-69","DOI":"10.1007\/s12035-015-9248-5","article-title":"Ketamine-Induced Toxicity in Neurons Differentiated from Neural Stem Cells.","volume":"52","author":"W Slikker","year":"2015","journal-title":"Mol Neurobiol."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"41-70","DOI":"10.1016\/0165-0173(90)90011-C","article-title":"Physiological and pathophysiological roles of excitatory amino acids during central nervous system development.","volume":"15","author":"J McDonald","year":"1990","journal-title":"Brain Res Brain Res Rev."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"4596-601","DOI":"10.1073\/pnas.1311141111","article-title":"Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.","volume":"111","author":"O Khwaja","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fpsyt.2012.00034","article-title":"Rett syndrome: genes, synapses, circuits, and therapeutics.","volume":"3","author":"A Banerjee","year":"2012","journal-title":"Front Psychiatry."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"327-31","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.","volume":"27","author":"R Chen","year":"2001","journal-title":"Nat Genet."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"2029-34","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice.","volume":"106","author":"D Tropea","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"9941-6","DOI":"10.1073\/pnas.1311685111","article-title":"Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome.","volume":"111","author":"J Castro","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"14230-5","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.","volume":"109","author":"R Deogracias","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"e100215","DOI":"10.1371\/journal.pone.0100215","article-title":"VPA alleviates neurological deficits and restores gene expression in a mouse model of Rett syndrome.","volume":"9","author":"W Guo","year":"2014","journal-title":"PLoS One."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/4-1490\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/4-1490\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/4-1490\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T14:45:41Z","timestamp":1554216341000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/4-1490\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,22]]},"references-count":58,"URL":"https:\/\/doi.org\/10.12688\/f1000research.6987.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.7524.r11699","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.7524.r11698","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.7524.r11698","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.7524.r11699","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,22]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/4-1490\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.7524.r11698, Zhi-Qi Xiong, Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China, 22 Dec 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-1490\/v1#referee-response-11698","order":0,"name":"referee-response-11698","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.7524.r11699, Thierry Bienvenu, AP-HP, Laboratoire de Biochimie et G\u00e9n\u00e9tique Mol\u00e9culaire, AP-HP, Laboratoire de Biochimie et G\u00e9n\u00e9tique Mol\u00e9culaire, GH Cochin-Broca-H\u00f4tel Dieu, Paris, France and Universit\u00e9 Paris Descartes Paris, Institut Cochin, INSERM U1016, Paris, France, 22 Dec 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-1490\/v1#referee-response-11699","order":1,"name":"referee-response-11699","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by FDA Grant 5RO1FD004247 and NIH-NICHD U54 HD079123.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}